Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins
- PMID: 20537997
- PMCID: PMC3038676
- DOI: 10.1053/j.gastro.2010.06.009
Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins
Abstract
Background & aims: Plasma levels of gamma-glutamyl transpeptidase (GGT) are associated with risk factors for nonalcoholic fatty liver disease (NAFLD), such as dyslipidemia, insulin resistance (IR), and hypertension. Limited data exist on whether there is genetic covariance between plasma levels of GGT and NAFLD risk factors. Variants of beta2-adrenergic receptor gene (ADRB2) have been associated with dyslipidemia, IR, and hypertension, but its effect on GGT secretion is not known. We estimated the heritability of GGT using a twin-study design and examined the genetic covariance between GGT levels, IR, hypertension, levels of low-density lipoproteins and triglycerides, and ADRB2 variants.
Methods: We studied phenotypes of 362 twins; the heritabilities of increased GGT activity and genetic covariance with NAFLD risk factors were estimated by variance-component methodology. ADRB2 genotype associations with plasma GGT activity were examined using generalized estimating equations to account for intra-twinship correlations.
Results: GGT activity was heritable at 49% +/- 8% of the twin cohort and had significant covariance with IR; insulin, triglyceride, and uric acid levels; and diastolic blood pressure. In generalized estimating equation models, the most common haplotype of ADRB2 was significantly associated with plasma GGT activity. Five single nucleotide polymorphisms in ADRB2 were associated with levels of GGT; ADRB2 haplotypes displayed pleiotropic effects on GGT and triglyceride levels.
Conclusions: In a twin study, GGT shared genetic codetermination with traits of metabolic syndrome. The ADRB2 gene had pleiotropic effects on plasma levels of GGT and triglycerides, indicating linked pathways (eg, adrenergic) between genetic susceptibility to NAFLD and metabolic syndrome.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures




Similar articles
-
C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.J Hypertens. 2007 Feb;25(2):329-43. doi: 10.1097/HJH.0b013e328011753e. J Hypertens. 2007. PMID: 17211240
-
Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.Kaohsiung J Med Sci. 2021 Sep;37(9):819-827. doi: 10.1002/kjm2.12395. Epub 2021 May 17. Kaohsiung J Med Sci. 2021. PMID: 34002481 Free PMC article.
-
Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function.Hypertension. 2005 Aug;46(2):301-7. doi: 10.1161/01.HYP.0000175842.19266.95. Epub 2005 Jul 18. Hypertension. 2005. PMID: 16027244
-
Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?Circ Res. 2015 Feb 27;116(5):909-22. doi: 10.1161/CIRCRESAHA.116.302888. Circ Res. 2015. PMID: 25722444 Free PMC article. Review.
-
Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise.Exerc Sport Sci Rev. 2008 Apr;36(2):98-105. doi: 10.1097/JES.0b013e318168f276. Exerc Sport Sci Rev. 2008. PMID: 18362692 Free PMC article. Review.
Cited by
-
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study.BMC Gastroenterol. 2020 Jul 10;20(1):217. doi: 10.1186/s12876-020-01369-x. BMC Gastroenterol. 2020. PMID: 32650722 Free PMC article.
-
The global NAFLD epidemic.Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17. Nat Rev Gastroenterol Hepatol. 2013. PMID: 24042449 Review.
-
β-Adrenergic agonist and antagonist regulation of autophagy in HepG2 cells, primary mouse hepatocytes, and mouse liver.PLoS One. 2014 Jun 20;9(6):e98155. doi: 10.1371/journal.pone.0098155. eCollection 2014. PLoS One. 2014. PMID: 24950230 Free PMC article.
-
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.Hepatology. 2012 Sep;56(3):943-51. doi: 10.1002/hep.25772. Epub 2012 Jul 26. Hepatology. 2012. PMID: 22505194 Free PMC article.
-
Genetic insights into cardiometabolic risk factors.Clin Biochem Rev. 2014 Feb;35(1):15-36. Clin Biochem Rev. 2014. PMID: 24659834 Free PMC article. Review.
References
-
- Ruttenburg AM, Goldbarg JA, Pineda EP. Serum Gamma-Glutamyl Transpeptidase Activity in Hepatobiliary Pancreatic Disease. Gastroenterology. 1963;45:43–48. - PubMed
-
- Nemesanszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem. 1985;31:797–803. - PubMed
-
- Irie M, Suzuki N, Sohda T, Anan A, Iwata K, Takeyama Y, Watanabe H, et al. Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res. 2007;37:966–973. - PubMed
-
- Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263–355. - PubMed
-
- Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens. 1994;8:95–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous